Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson's Disease.
Erjola BejPatrizia CesareAnna Rita VolpeMichele D'AngeloVanessa CastelliPublished in: Neurology international (2024)
Parkinson's disease (PD) is a progressive neurodegenerative condition marked by the gradual deterioration of dopaminergic neurons in the substantia nigra . Oxidative stress has been identified as a key player in the development of PD in recent studies. In the first part, we discuss the sources of oxidative stress in PD, including mitochondrial dysfunction, dopamine metabolism, and neuroinflammation. This paper delves into the possibility of mitigating oxidative stress as a potential treatment approach for PD. In addition, we examine the hurdles and potential of antioxidant therapy, including the challenge of delivering antioxidants to the brain and the requirement for biomarkers to track oxidative stress in PD patients. However, even if antioxidant therapy holds promise, further investigation is needed to determine its efficacy and safety in PD treatment.
Keyphrases
- oxidative stress
- dna damage
- diabetic rats
- ischemia reperfusion injury
- induced apoptosis
- end stage renal disease
- multiple sclerosis
- newly diagnosed
- chronic kidney disease
- traumatic brain injury
- ejection fraction
- prognostic factors
- heat shock
- spinal cord
- stem cells
- inflammatory response
- peritoneal dialysis
- machine learning
- brain injury
- resting state
- functional connectivity
- replacement therapy
- lps induced
- risk assessment
- spinal cord injury
- smoking cessation
- combination therapy
- uric acid
- heat stress